Literature DB >> 2211986

Attenuation of experimental autoimmune encephalomyelitis by Compound 48/80 in Lewis rats.

N C Stanley1, F L Jackson, E L Orr.   

Abstract

The appearance of increased levels of histamine in the central nervous system (CNS) concomitant with the development of clinically significant acute experimental autoimmune encephalomyelitis (EAE) in male Lewis rats suggests that CNS-associated mast cells may mediate acute EAE in Lewis rats. We now report that, compared to controls, rats with acute EAE exhibit fewer detectable mast cells in their dura mater and velum interpositum. In addition, intracisternal, but not intraperitoneal administration of Compound 48/80 just prior to the appearance of clinical signs of acute or recurrent EAE in male and female rats, respectively, significantly attenuates the clinical severity of both forms of EAE. These results further support the hypothesis that CNS-associated, but not peripheral mast cells are mediators or modulators of acute and recurrent EAE in Lewis rats.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2211986     DOI: 10.1016/0165-5728(90)90165-j

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  6 in total

Review 1.  Mast cell specific proteases in rat brain: changes in rats with experimental allergic encephalomyelitis.

Authors:  A Rouleau; V Dimitriadou; M D Trung Tuong; G F Newlands; H R Miller; J C Schwartz; M Garbarg
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

2.  Endothelial histamine H1 receptor signaling reduces blood-brain barrier permeability and susceptibility to autoimmune encephalomyelitis.

Authors:  Changming Lu; Sean A Diehl; Rajkumar Noubade; Jonathan Ledoux; Mark T Nelson; Karen Spach; James F Zachary; Elizabeth P Blankenhorn; Cory Teuscher
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-18       Impact factor: 11.205

3.  Central histamine H3 receptor signaling negatively regulates susceptibility to autoimmune inflammatory disease of the CNS.

Authors:  Cory Teuscher; Meena Subramanian; Rajkumar Noubade; Jian Feng Gao; Halina Offner; James F Zachary; Elizabeth P Blankenhorn
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-04       Impact factor: 11.205

4.  Elevated CSF histamine levels in multiple sclerosis patients.

Authors:  Ulf Kallweit; Kosuke Aritake; Claudio L Bassetti; Stephan Blumenthal; Osamu Hayaishi; Michael Linnebank; Christian R Baumann; Yoshihiro Urade
Journal:  Fluids Barriers CNS       Date:  2013-05-09

5.  Histamine H(3) receptor-mediated signaling protects mice from cerebral malaria.

Authors:  Walid Beghdadi; Adeline Porcherie; Bradley S Schneider; Séverine Morisset; David Dubayle; Roger Peronet; Michel Dy; Jacques Louis; Jean-Michel Arrang; Salaheddine Mécheri
Journal:  PLoS One       Date:  2009-06-23       Impact factor: 3.240

Review 6.  Mast cells in the pathogenesis of multiple sclerosis and experimental autoimmune encephalomyelitis.

Authors:  Massimo Costanza; Mario P Colombo; Rosetta Pedotti
Journal:  Int J Mol Sci       Date:  2012-11-16       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.